{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Hydrocortisone+Oral&page=2", "query": { "intervention": "Hydrocortisone Oral", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Hydrocortisone+Oral&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-27T16:35:08.358Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00001521", "title": "Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Congenital Adrenal Hyperplasia (CAH)" ], "interventions": [ { "name": "Fludrocortisone", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" }, { "name": "Letrozole", "type": "DRUG" }, { "name": "Flutamide", "type": "DRUG" }, { "name": "Testolactone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Years to 18 Years" }, "enrollment_count": 66, "start_date": "1995-06-08", "completion_date": "2024-04-01", "has_results": true, "last_update_posted_date": "2025-06-12", "last_synced_at": "2026-09-27T16:35:08.358Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001521" }, { "nct_id": "NCT01710202", "title": "Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Major Depressive Disorder", "Anxiety Disorders" ], "interventions": [ { "name": "Hydrocortisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas at Austin", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2012-10", "completion_date": "2014-11", "has_results": false, "last_update_posted_date": "2015-03-20", "last_synced_at": "2026-09-27T16:35:08.358Z", "location_count": 2, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01710202" }, { "nct_id": "NCT04037605", "title": "Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Sleep Restriction" ], "interventions": [ { "name": "Ketoconazole Pill (also known as nizoral)", "type": "DRUG" }, { "name": "Ganirelix", "type": "DRUG" }, { "name": "Dexamethasone Pill", "type": "DRUG" }, { "name": "Dexamethasone injection", "type": "DRUG" }, { "name": "Cosyntropin Injectable Product", "type": "DRUG" }, { "name": "Recombinant Human Luteinizing Hormone (also known as luveris)", "type": "DRUG" }, { "name": "Hydrocortisone Injection (also known as solu-cortef)", "type": "DRUG" }, { "name": "Gonadorelin (also known as Lutrepulse)", "type": "DRUG" }, { "name": "Corticorelin (also known as Acthrel)", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" }, { "name": "Saline Solution", "type": "DRUG" }, { "name": "Saline solution for injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "60 Years to 80 Years" }, "enrollment_count": 5, "start_date": "2020-02-09", "completion_date": "2026-06-24", "has_results": false, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-09-27T16:35:08.358Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04037605" }, { "nct_id": "NCT02270788", "title": "Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Myeloid Leukemia" ], "interventions": [ { "name": "Crenolanib", "type": "DRUG" }, { "name": "Sorafenib", "type": "DRUG" }, { "name": "methotrexate, hydrocortisone and cytarabine with leucovorin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "39 Years", "sex": "ALL", "summary": "1 Year to 39 Years" }, "enrollment_count": 10, "start_date": "2015-04-02", "completion_date": "2016-10-17", "has_results": false, "last_update_posted_date": "2017-10-03", "last_synced_at": "2026-09-27T16:35:08.358Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02270788" }, { "nct_id": "NCT03896659", "title": "Exploring the Effects of Corticosteroids on the Human Hippocampus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hydrocortisone", "Depression", "Healthy Volunteers" ], "interventions": [ { "name": "Hydrocortisone Oral", "type": "DRUG" }, { "name": "Placebo Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 66, "start_date": "2019-10-01", "completion_date": "2024-09-16", "has_results": true, "last_update_posted_date": "2025-12-16", "last_synced_at": "2026-09-27T16:35:08.358Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03896659" }, { "nct_id": "NCT03718234", "title": "Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Congenital Adrenal Hyperplasia", "Hyperplasia", "Adrenal Hyperplasia", "Congenital Disorders", "Adrenocortical Hyperfunction", "Disorders of Sex Development", "Urogenital Abnormalities", "Genetic Diseases, Inborn", "Steroid Metabolic Diseases, Inborn", "Adrenal Gland Disease", "Hydrocortisone" ], "interventions": [ { "name": "Subcutaneous hydrocortisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "4 Years to 18 Years" }, "enrollment_count": 11, "start_date": "2019-01-01", "completion_date": "2023-02-23", "has_results": true, "last_update_posted_date": "2025-06-25", "last_synced_at": "2026-09-27T16:35:08.358Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03718234" }, { "nct_id": "NCT00440726", "title": "Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Acute Lymphoblastic Leukemia" ], "interventions": [ { "name": "Bortezomib", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "PEG-asparaginase", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Triple IT Therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Therapeutic Advances in Childhood Leukemia Consortium", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Year to 21 Years" }, "enrollment_count": 31, "start_date": "2006-08-04", "completion_date": "2011-02-26", "has_results": true, "last_update_posted_date": "2020-02-19", "last_synced_at": "2026-09-27T16:35:08.358Z", "location_count": 20, "location_summary": "Duarte, California • Long Beach, California • Los Angeles, California + 16 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00440726" }, { "nct_id": "NCT04924166", "title": "PTSD Prevention Using Oral Hydrocortisone", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "PTSD", "Acute Stress Disorder", "Trauma-related Stressor" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rachel Yehuda", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 201, "start_date": "2022-01-12", "completion_date": "2025-07-06", "has_results": false, "last_update_posted_date": "2026-03-19", "last_synced_at": "2026-09-27T16:35:08.358Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04924166" }, { "nct_id": "NCT03548246", "title": "Androgen Reduction in Congenital Adrenal Hyperplasia", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Congenital Adrenal Hyperplasia" ], "interventions": [ { "name": "Abiraterone acetate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Hydrocortisone", "type": "DRUG" }, { "name": "Fludrocortisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "9 Years", "sex": "ALL", "summary": "2 Years to 9 Years" }, "enrollment_count": 0, "start_date": "2023-01", "completion_date": "2026-01", "has_results": false, "last_update_posted_date": "2023-02-01", "last_synced_at": "2026-09-27T16:35:08.358Z", "location_count": 4, "location_summary": "Los Angeles, California • Bethesda, Maryland • Ann Arbor, Michigan + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03548246" }, { "nct_id": "NCT06533748", "title": "Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lymphoblastic Leukemia", "Lymphoblastic Lymphoma" ], "interventions": [ { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Inotuzumab", "type": "DRUG" }, { "name": "Blinatumomab", "type": "DRUG" }, { "name": "Dasatinib", "type": "DRUG" }, { "name": "IT MHA", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "6-Mercaptopurine", "type": "DRUG" }, { "name": "Calaspargase", "type": "DRUG" }, { "name": "Daunorubicin", "type": "DRUG" }, { "name": "Thioguanine", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "18 Years", "sex": "ALL", "summary": "1 Year to 18 Years" }, "enrollment_count": 128, "start_date": "2025-01-23", "completion_date": "2034-05", "has_results": false, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-09-27T16:35:08.358Z", "location_count": 3, "location_summary": "Charlotte, North Carolina • Tulsa, Oklahoma • Memphis, Tennessee", "locations": [ { "city": "Charlotte", "state": "North Carolina" }, { "city": "Tulsa", "state": "Oklahoma" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06533748" } ] }